The study suggests that a less common version of the brain-derived neurotropic factor (BDNF) gene may predispose people to obesity by producing lower levels of BDNF protein, a regulator of appetite, in the brain.
The researchers propose that boosting BDNF protein levels may offer a therapeutic strategy for people with the genetic variation, which tends to occur more frequently in African Americans and Hispanics, than in non-Hispanic Caucasians.
"This study explains how a single genetic change in BDNF influences obesity and may affect BDNF protein levels. Finding people with specific causes of obesity may allow us to evaluate effective, more-personalised treatments," said Jack A Yanovski, an investigator at US National Institute of Child Health and Human Development (NICHD).
The researchers identified an area of the gene where a single change reduced BDNF levels in the hypothalamus, a key area that controls eating and body weight.
The genetic change the researchers identified was not a rare mutation, but rather a variation that occurs in the general population.
Every person has two copies, or alleles, of each gene, inheriting one copy from each parent. In their study, the researchers referred to the common allele as "T," and the less common allele, which produces less BDNF protein, as "C."
They compared a person's BDNF gene combination - CC, CT or TT - to factors that define obesity, such as body mass index (BMI) and percentage of body fat.
In African American adults, the team found that the C allele was associated with higher BMI and body fat percentage in those with CT or CC types.
In a group of healthy children of many races, the researchers found that CC types had higher BMI scores and percentage of body fat when compared to CT or TT types, who were similar to each other.
Overall, the study suggests that the C allele of the BDNF gene may be linked to obesity in people.
"Lower BDNF levels may contribute to obesity in people with the C allele. If these findings are supported by additional studies, boosting BDNF levels may prove beneficial," said Joan C Han, a former NICHD investigator now at the University of Tennessee Health Science Center, who led the study.
The study was published in the journal Cell Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
